Aristo Bio-Tech and Lifescience Ltd.

•

aristobiotech.comBSE: -NSE: ARISTO

Market Cap₹ 70 Cr.

Current Price

High / Low₹ 140 / 74

Stock P/E9.8

Book Value₹ 55

Price to Book2.12

Dividend Yield0.58 %

ROCE13.0 %

ROE11.5 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence

55%

View full sector analysis →

PROS

Company has delivered good profit growth of 32.2% CAGR over last 5 years
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.29x)
Working capital cycle has improved - days down from 32 to 23
Company generates healthy free cash flow
Attractively priced for its growth - PEG of 0.2

CONS

Equity base is being diluted - shares outstanding up 36.3%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsPesticides & Agrochemicals

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	UPL	576.05	24.07	48628.37	1.04	-73.00	58.52	10181.00	10.47	12.00	13.43
2.	PIIND	2390.55	31.13	36268.97	0.63	244.20	-38.95	1702.30	-10.43	16.00	21.69
3.	SUMICHEM	505.00	43.50	25206.86	0.26	214.51	20.45	1063.35	0.62	23.39	21.94
4.	BAYERCROP	3980.70	322.87	17890.10	3.77	321.60	15.39	1835.00	-4.16	30.08	20.03
5.	SHARDACROP	778.45	11.22	7023.21	1.93	88.02	-38.36	1073.77	9.03	31.10	17.32
6.	DHANUKA	994.20	14.92	4431.98	0.20	75.50	27.94	442.02	20.01	24.44	24.83
7.	RALLIS	209.55	24.82	4075.10	1.43	-14.15	-274.26	507.54	7.70	13.23	-0.56
8.	NACLIND	167.45	317.09	3922.40	0.00	20.84	59.82	383.33	-14.50	6.20	10.80
9.	BHAGCHEM	267.95	126.24	3474.48	0.06	133.29	3249.84	1950.19	1475.55	4.55	15.65
10.	GSPCROP	626.60	29.78	2914.86	0.16	263.94	1111.46	3859.95	1153.27	18.46	11.02
11.	BHARATRAS	1204.30	13.97	2001.68	0.04	372.30	838.73	3381.60	796.03	16.63	15.19
12.	ARISTO	103.00	9.76	70.12	0.58	—	—	—	—	12.96	—

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

No quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	202	201	167	166	218	245	318
	195	197	163	161	209	237	309
Operating Profit	7	5	5	5	9	9	10
OPM %	3	2	3	3	4	4	3
Other Income	0	0	0	0	0	0	1
Interest	2	3	2	2	3	2	2
Depreciation	1	1	1	1	2	2	3
	4	1	1	2	5	5	5
Tax %	31	28	28	28	25	28	26
Net Profit	3	1	1	1	4	4	4
EPS	6	2	2	3	7	6	6
Dividend Payout %	0	0	0	0	5	7	8
Minority Interest	0	0	0	0	0	0	0
Share of Associates	0	0	0	0	0	0	0
Adjusted EPS	6	2	2	3	5	6	6

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 10%
3 Years:: 24%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 32%
3 Years:: 42%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: 6%
1 Year:: -21%

RETURN ON EQUITY

10 Years:: —
5 Years:: 12%
3 Years:: 13%
Last Year:: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
LIABILITIES	-	-	-	-	-	-	-
Equity Capital	5	5	5	5	7	7	7
	6	7	8	10	23	27	31
	6	8	9	13	10	8	11
Trade Payables	63	38	38	35	45	69	78
	11	30	20	14	14	16	14
Total Liabilities	91	88	81	77	100	127	141
ASSETS	-	-	-	-	-	-	-
	8	8	12	14	16	22	24
Capital Work in Progress	1	3	0	0	1	0	0
	33	24	32	24	31	40	47
	0	0	0	0	0	57	56
Cash & Bank	0	1	0	0	2	1	1
	48	52	37	38	50	7	12
Total Assets	91	88	81	77	100	127	141
Total Debt	14	20	22	25	22	21	22
Net Working Capital	9	12	13	12	23	21	20
Contingent Liabilities	2	1	0	1	1	0	0
Book Value per Share	22.62	24.63	26.79	29.76	44.30	49.37	54.84
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	8	1	2	7	-3	8	10
Cash from Investing	-2	-2	-2	-3	-4	-7	-5
Cash from Financing	-6	1	-1	-3	8	-2	-4
	-0	0	-0	0	1	-1	0
Free Cash Flow	8	-1	0	4	-7	1	5
OCF / Net Profit	2.88	1.40	2.12	4.73	-0.78	1.95	2.47
Cumulative 5-Year FCF	0	0	0	0	0	-2	4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	5.66	2.02	2.15	2.87	5.23	5.72	5.97
Book Value (₹)	22.62	24.63	26.79	29.76	44.30	49.37	54.84
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.25	0.40	0.50
Cash EPS (₹)	6.68	3.06	3.65	5.07	7.49	8.03	9.79
PROFITABILITY
Operating Margin %	2.95%	1.92%	2.33%	3.28%	4.14%	3.44%	2.92%
Net Margin %	1.21%	0.43%	0.55%	0.86%	1.64%	1.59%	1.28%
ROE %	25.03%	8.54%	8.38%	10.15%	15.82%	12.22%	11.46%
ROCE %	24.67%	13.84%	11.27%	11.43%	16.11%	13.41%	12.96%
	3.12%	1.13%	1.27%	1.81%	4.03%	3.43%	3.03%
EFFICIENCY
Debtor Days	66	70	75	73	65	76	65
Inventory Days	51	44	52	62	46	53	50
Payable Days	124	98	93	91	75	93	91
	-7	17	35	43	36	36	24
FINANCIAL HEALTH
Debt to Equity (x)	1.28x	1.60x	1.66x	1.71x	0.75x	0.62x	0.59x
Interest Coverage (x)	2.82x	1.54x	1.65x	1.84x	2.72x	4.05x	3.88x
	1.12x	1.18x	1.23x	1.23x	1.39x	1.26x	1.21x
GROWTH
Revenue Growth %	0.00%	-0.22%	-16.90%	-0.87%	31.43%	12.53%	29.76%
Operating Profit Growth %	0.00%	-34.79%	1.01%	19.31%	65.89%	-3.06%	13.87%
Net Profit Growth %	0.00%	-64.38%	6.78%	33.29%	148.44%	9.36%	4.30%
	0.00%	0.00%	0.00%	0.00%	0.00%	9.36%	4.30%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	10.91x	19.47x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	1.27x	2.12x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.64%	0.43%
	0.00x	0.00x	0.00x	0.00x	0.00x	7.17x	10.02x

Shareholding Pattern

Numbers in percentages

	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
	73.37	73.37	73.37	73.37	73.42	73.42	73.42
FIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00
DIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	26.62	26.63	26.63	26.63	26.58	26.58	26.58

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for ARISTO

Loading news…

🤖

AI Stock Analyst

Aristo Bio-Tech and Lifescience Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

UPL

576.05

24.07

48628.37

1.04

-73.00

58.52

10181.00

10.47

12.00

13.43

PIIND

2390.55

31.13

36268.97

0.63

244.20

-38.95

1702.30

-10.43

16.00

21.69

SUMICHEM

505.00

43.50

25206.86

0.26

214.51

20.45

1063.35

0.62

23.39

21.94

BAYERCROP

3980.70

322.87

17890.10

3.77

321.60

15.39

1835.00

-4.16

30.08

20.03

SHARDACROP

778.45

11.22

7023.21

1.93

88.02

-38.36

1073.77

9.03

31.10

17.32

DHANUKA

994.20

14.92

4431.98

0.20

75.50

27.94

442.02

20.01

24.44

24.83

RALLIS

209.55

24.82

4075.10

1.43

-14.15

-274.26

507.54

7.70

13.23

-0.56

NACLIND

167.45

317.09

3922.40

0.00

20.84

59.82

383.33

-14.50

6.20

10.80

BHAGCHEM

267.95

126.24

3474.48

0.06

133.29

3249.84

1950.19

1475.55

4.55

15.65

GSPCROP

626.60

29.78

2914.86

0.16

263.94

1111.46

3859.95

1153.27

18.46

11.02

BHARATRAS

1204.30

13.97

2001.68

0.04

372.30

838.73

3381.60

796.03

16.63

15.19

ARISTO

103.00

9.76

70.12

0.58

—

12.96

—

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

202

201

167

166

218

245

318

195

197

163

161

209

237

309

Operating Profit

OPM %

Other Income

Interest

Depreciation

Tax %

Net Profit

EPS

Dividend Payout %

Minority Interest

Share of Associates

Adjusted EPS

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

LIABILITIES

Equity Capital

Trade Payables

Total Liabilities

100

127

141

ASSETS

Capital Work in Progress

Cash & Bank

Total Assets

100

127

141

Total Debt

Net Working Capital

Contingent Liabilities

Book Value per Share

22.62

24.63

26.79

29.76

44.30

49.37

54.84

Face Value

10.00

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

-3

Cash from Investing

-2

-3

-4

-7

-5

Cash from Financing

-6

-1

-3

-2

-4

-0

-1

Free Cash Flow

-1

-7

OCF / Net Profit

2.88

1.40

2.12

4.73

-0.78

1.95

2.47

Cumulative 5-Year FCF

-2

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

5.66

2.02

2.15

2.87

5.23

5.72

5.97

Book Value (₹)

22.62

24.63

26.79

29.76

44.30

49.37

54.84

Dividend per Share (₹)

0.00

0.25

0.40

0.50

Cash EPS (₹)

6.68

3.06

3.65

5.07

7.49

8.03

9.79

PROFITABILITY

Operating Margin %

2.95%

1.92%

2.33%

3.28%

4.14%

3.44%

2.92%

Net Margin %

1.21%

0.43%

0.55%

0.86%

1.64%

1.59%

1.28%

ROE %

25.03%

8.54%

8.38%

10.15%

15.82%

12.22%

11.46%

ROCE %

24.67%

13.84%

11.27%

11.43%

16.11%

13.41%

12.96%

3.12%

1.13%

1.27%

1.81%

4.03%

3.43%

3.03%

EFFICIENCY

Debtor Days

Inventory Days

Payable Days

124

-7

FINANCIAL HEALTH

Debt to Equity (x)

1.28x

1.60x

1.66x

1.71x

0.75x

0.62x

0.59x

Interest Coverage (x)

2.82x

1.54x

1.65x

1.84x

2.72x

4.05x

3.88x

1.12x

1.18x

1.23x

1.39x

1.26x

1.21x

GROWTH

Revenue Growth %

0.00%

-0.22%

-16.90%

-0.87%

31.43%

12.53%

29.76%

Operating Profit Growth %

0.00%

-34.79%

1.01%

19.31%

65.89%

-3.06%

13.87%

Net Profit Growth %

0.00%

-64.38%

6.78%

33.29%

148.44%

9.36%

4.30%

0.00%

9.36%

4.30%

VALUATION

P/E (x)

0.00x

10.91x

19.47x

P/B (x)

0.00x

1.27x

2.12x

Dividend Yield %

0.00%

0.64%

0.43%

0.00x

7.17x

10.02x

Mar 2023

Sep 2023

Mar 2024

Sep 2024

Mar 2025

Sep 2025

Mar 2026

73.37

73.42

FIIs

0.00

DIIs

0.00

Government

0.00

26.62

26.63

26.58

Aristo Bio-Tech and Lifescience Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Aristo Bio-Tech and Lifescience Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI